Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia

Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and...

Full description

Saved in:
Bibliographic Details
Published inThe journal of gene medicine Vol. 19; no. 11; pp. 353 - 359
Main Authors Wang, Shu‐Mei, Zeng, Wei‐Xin, Wu, Wan‐Shui, Sun, Lu‐Lu, Yan, Dan
Format Journal Article
LanguageEnglish
Published England Wiley Periodicals Inc 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and rs35134728 DEL/TTC) in the 3′‐untranslated region of MTHFR with serum MTX concentrations, in a Chinese pediatric population with ALL. Methods Genotyping for MTHFR rs3737966 and rs35134728 in 144 children with ALL was performed using the Sequenom MassArray system (Sequenom, San Diego, CA, USA). Serum MTX concentrations were measured by a fluorescence polarization immunoassay 24 h (C24h) and 42 h (C42h) after administration. The effects of the polymorphisms on concentration‐to‐dose (C/D) ratios of MTX were assessed. Results Complete linkage disequilibrium between rs3737966 and rs35134728 polymorphisms (r2 = 1) was found in the study population. The minor allele frequency observed in the present study (17.4%) was significantly lower than those in European and African samples reported in the 1000 Genomes Project (42.9% and 63.9%, respectively; p < 0.01). The C/D ratios of MTX at 24 and 42 h for the TTC/TTC‐A/A haplotype carriers (11.74 and 0.07 μmol/l per g/m2, respectively) were significantly lower than those in DEL/DEL‐G/G or DEL/TTC‐G/G haplotype carriers (12.49 and 0.09 μmol/l per g/m2, respectively; p < 0.05). Computational predictions suggested that the two polymorphisms overlapped with putative binding sites of several miRNAs. Conclusions The rs3737966 and rs35134728 polymorphisms in MTHFR were associated with serum MTX concentrations. The findings of the present study indicate that miRNAs might be involved in the post‐transcriptional regulation of MTHFR.
AbstractList Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and rs35134728 DEL/TTC) in the 3′‐untranslated region of MTHFR with serum MTX concentrations, in a Chinese pediatric population with ALL. Methods Genotyping for MTHFR rs3737966 and rs35134728 in 144 children with ALL was performed using the Sequenom MassArray system (Sequenom, San Diego, CA, USA). Serum MTX concentrations were measured by a fluorescence polarization immunoassay 24 h (C24h) and 42 h (C42h) after administration. The effects of the polymorphisms on concentration‐to‐dose (C/D) ratios of MTX were assessed. Results Complete linkage disequilibrium between rs3737966 and rs35134728 polymorphisms (r2 = 1) was found in the study population. The minor allele frequency observed in the present study (17.4%) was significantly lower than those in European and African samples reported in the 1000 Genomes Project (42.9% and 63.9%, respectively; p < 0.01). The C/D ratios of MTX at 24 and 42 h for the TTC/TTC‐A/A haplotype carriers (11.74 and 0.07 μmol/l per g/m2, respectively) were significantly lower than those in DEL/DEL‐G/G or DEL/TTC‐G/G haplotype carriers (12.49 and 0.09 μmol/l per g/m2, respectively; p < 0.05). Computational predictions suggested that the two polymorphisms overlapped with putative binding sites of several miRNAs. Conclusions The rs3737966 and rs35134728 polymorphisms in MTHFR were associated with serum MTX concentrations. The findings of the present study indicate that miRNAs might be involved in the post‐transcriptional regulation of MTHFR.
Abstract Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and rs35134728 DEL/TTC) in the 3′‐untranslated region of MTHFR with serum MTX concentrations, in a Chinese pediatric population with ALL. Methods Genotyping for MTHFR rs3737966 and rs35134728 in 144 children with ALL was performed using the Sequenom MassArray system (Sequenom, San Diego, CA, USA). Serum MTX concentrations were measured by a fluorescence polarization immunoassay 24 h ( C 24h ) and 42 h ( C 42h ) after administration. The effects of the polymorphisms on concentration‐to‐dose ( C / D ) ratios of MTX were assessed. Results Complete linkage disequilibrium between rs3737966 and rs35134728 polymorphisms ( r 2  = 1) was found in the study population. The minor allele frequency observed in the present study (17.4%) was significantly lower than those in European and African samples reported in the 1000 Genomes Project (42.9% and 63.9%, respectively; p  < 0.01). The C / D ratios of MTX at 24 and 42 h for the TTC/TTC‐A/A haplotype carriers (11.74 and 0.07 μmol/l per g/m 2 , respectively) were significantly lower than those in DEL/DEL‐G/G or DEL/TTC‐G/G haplotype carriers (12.49 and 0.09 μmol/l per g/m 2 , respectively; p  < 0.05). Computational predictions suggested that the two polymorphisms overlapped with putative binding sites of several miRNAs. Conclusions The rs3737966 and rs35134728 polymorphisms in MTHFR were associated with serum MTX concentrations. The findings of the present study indicate that miRNAs might be involved in the post‐transcriptional regulation of MTHFR.
BACKGROUNDThe pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and rs35134728 DEL/TTC) in the 3'-untranslated region of MTHFR with serum MTX concentrations, in a Chinese pediatric population with ALL.METHODSGenotyping for MTHFR rs3737966 and rs35134728 in 144 children with ALL was performed using the Sequenom MassArray system (Sequenom, San Diego, CA, USA). Serum MTX concentrations were measured by a fluorescence polarization immunoassay 24 h (C24h ) and 42 h (C42h ) after administration. The effects of the polymorphisms on concentration-to-dose (C/D) ratios of MTX were assessed.RESULTSComplete linkage disequilibrium between rs3737966 and rs35134728 polymorphisms (r2  = 1) was found in the study population. The minor allele frequency observed in the present study (17.4%) was significantly lower than those in European and African samples reported in the 1000 Genomes Project (42.9% and 63.9%, respectively; p < 0.01). The C/D ratios of MTX at 24 and 42 h for the TTC/TTC-A/A haplotype carriers (11.74 and 0.07 μmol/l per g/m2 , respectively) were significantly lower than those in DEL/DEL-G/G or DEL/TTC-G/G haplotype carriers (12.49 and 0.09 μmol/l per g/m2 , respectively; p < 0.05). Computational predictions suggested that the two polymorphisms overlapped with putative binding sites of several miRNAs.CONCLUSIONSThe rs3737966 and rs35134728 polymorphisms in MTHFR were associated with serum MTX concentrations. The findings of the present study indicate that miRNAs might be involved in the post-transcriptional regulation of MTHFR.
The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and rs35134728 DEL/TTC) in the 3'-untranslated region of MTHFR with serum MTX concentrations, in a Chinese pediatric population with ALL. Genotyping for MTHFR rs3737966 and rs35134728 in 144 children with ALL was performed using the Sequenom MassArray system (Sequenom, San Diego, CA, USA). Serum MTX concentrations were measured by a fluorescence polarization immunoassay 24 h (C ) and 42 h (C ) after administration. The effects of the polymorphisms on concentration-to-dose (C/D) ratios of MTX were assessed. Complete linkage disequilibrium between rs3737966 and rs35134728 polymorphisms (r  = 1) was found in the study population. The minor allele frequency observed in the present study (17.4%) was significantly lower than those in European and African samples reported in the 1000 Genomes Project (42.9% and 63.9%, respectively; p < 0.01). The C/D ratios of MTX at 24 and 42 h for the TTC/TTC-A/A haplotype carriers (11.74 and 0.07 μmol/l per g/m , respectively) were significantly lower than those in DEL/DEL-G/G or DEL/TTC-G/G haplotype carriers (12.49 and 0.09 μmol/l per g/m , respectively; p < 0.05). Computational predictions suggested that the two polymorphisms overlapped with putative binding sites of several miRNAs. The rs3737966 and rs35134728 polymorphisms in MTHFR were associated with serum MTX concentrations. The findings of the present study indicate that miRNAs might be involved in the post-transcriptional regulation of MTHFR.
Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim of the present study was to investigate the association of two microRNA (miRNA) binding site polymorphisms (rs3737966 G > A and rs35134728 DEL/TTC) in the 3'-untranslated region of MTHFR with serum MTX concentrations, in a Chinese pediatric population with ALL. Methods Genotyping for MTHFR rs3737966 and rs35134728 in 144 children with ALL was performed using the Sequenom MassArray system (Sequenom, San Diego, CA, USA). Serum MTX concentrations were measured by a fluorescence polarization immunoassay 24 h (C24h) and 42 h (C42h) after administration. The effects of the polymorphisms on concentration-to-dose (C/D) ratios of MTX were assessed. Results Complete linkage disequilibrium between rs3737966 and rs35134728 polymorphisms (r2 = 1) was found in the study population. The minor allele frequency observed in the present study (17.4%) was significantly lower than those in European and African samples reported in the 1000 Genomes Project (42.9% and 63.9%, respectively; p < 0.01). The C/D ratios of MTX at 24 and 42 h for the TTC/TTC-A/A haplotype carriers (11.74 and 0.07 µmol/l per g/m2, respectively) were significantly lower than those in DEL/DEL-G/G or DEL/TTC-G/G haplotype carriers (12.49 and 0.09 µmol/l per g/m2, respectively; p < 0.05). Computational predictions suggested that the two polymorphisms overlapped with putative binding sites of several miRNAs. Conclusions The rs3737966 and rs35134728 polymorphisms in MTHFR were associated with serum MTX concentrations. The findings of the present study indicate that miRNAs might be involved in the post-transcriptional regulation of MTHFR.
Author Sun, Lu‐Lu
Wang, Shu‐Mei
Yan, Dan
Zeng, Wei‐Xin
Wu, Wan‐Shui
Author_xml – sequence: 1
  givenname: Shu‐Mei
  orcidid: 0000-0001-9121-8168
  surname: Wang
  fullname: Wang, Shu‐Mei
  email: wangshumei1980@126.com
  organization: Capital Medical University
– sequence: 2
  givenname: Wei‐Xin
  surname: Zeng
  fullname: Zeng, Wei‐Xin
  organization: Capital Medical University
– sequence: 3
  givenname: Wan‐Shui
  surname: Wu
  fullname: Wu, Wan‐Shui
  organization: Capital Medical University
– sequence: 4
  givenname: Lu‐Lu
  surname: Sun
  fullname: Sun, Lu‐Lu
  organization: Capital Medical University
– sequence: 5
  givenname: Dan
  surname: Yan
  fullname: Yan, Dan
  email: yd277_1@126.com
  organization: Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28990296$$D View this record in MEDLINE/PubMed
BookMark eNp1kV2L1TAQhoOsuB8K_gIJeONN1yRN2ubycNgPZVdhWcG7kqZztjk2SU1ajufH-F-d_VBB8CqBeeaZYd5jchBiAEJec3bKGRPvt3f-VGjNnpEjrgQvhFDyAP9M60Lq5ushOc55yxivm0a_IIeiQVjo6oj8XOUcrTOzi4F2MO8AAr2-vTy_od7ZFG8-rWjnQu_CHc1uBjrFce9jmgaXfaYm9NTDPMQ5wQ-DZRuDhTCnB2GmLtD14AJkbIQexyRn6YRFZDLduXmgxi7Yh9JpiN1o8ozECMs38M68JM83Zszw6uk9IV_Oz27Xl8XV54sP69VVYUupWSF0aZitlQAuragUbCSrpS6rGkypmJDCQi8NSGWqEk_TSF2zTijBemXKuixPyLtH75Ti9wXy3HqXLYyjCRCX3HKNY7Cr4oi-_QfdxiUF3A6pqtGqlqz6K8QT5pxg007JeZP2LWftfWQtRtbeR4bomyfh0nno_4C_M0KgeAR2boT9f0Xtx4vrB-EvL5qjkw
CitedBy_id crossref_primary_10_3389_fped_2023_1153767
crossref_primary_10_3390_hematolrep15040065
crossref_primary_10_3390_ijms19092688
crossref_primary_10_2174_1381612829666221025154714
crossref_primary_10_1080_17425255_2024_2332366
crossref_primary_10_2217_pgs_2017_0164
crossref_primary_10_3390_nu14214594
Cites_doi 10.1016/j.leukres.2007.03.028
10.1007/s10038-006-0096-z
10.1056/NEJM198311033091805
10.1056/NEJMra052603
10.1158/0008-5472.CAN-08-2129
10.1016/S0140-6736(08)60457-2
10.1093/carcin/bgr300
10.1007/s12185-013-1464-z
10.1111/j.1582-4934.2011.01359.x
10.1038/ng865
10.1158/0008-5472.CAN-09-3541
10.1038/leu.2008.66
10.3892/mmr.2014.2692
10.1038/ng0595-111
10.1002/pbc.23074
10.1073/pnas.1103360108
10.1097/01.mph.0000198269.61948.90
10.1053/j.seminhematol.2008.09.007
10.1007/s00277-005-0072-2
10.1016/j.clpt.2006.08.012
10.1159/000368104
10.1056/NEJM197709222971203
10.1097/MBC.0b013e32835b249d
10.1007/s00280-014-2507-8
10.1111/j.1365-2141.2009.07765.x
10.1016/j.gpb.2016.11.003
10.1111/j.1349-7006.2009.01429.x
10.1080/10428190902893819
10.1038/nrc2867
10.1073/pnas.0706217104
10.1155/2015/751703
10.1182/blood-2013-01-480335
ContentType Journal Article
Copyright Copyright © 2017 John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2017 John Wiley & Sons, Ltd.
DBID NPM
AAYXX
CITATION
7QP
7TK
7TM
8FD
FR3
K9.
P64
RC3
7X8
DOI 10.1002/jgm.2990
DatabaseName PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Genetics Abstracts
Technology Research Database
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
PubMed
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1521-2254
EndPage 359
ExternalDocumentID 10_1002_jgm_2990
28990296
JGM2990
Genre article
Journal Article
GrantInformation_xml – fundername: Beijing Key Laboratory of Bio‐characteristic Profiling for Evaluation of Rational Drug Use
  funderid: BZ0439
– fundername: National Natural Science Foundation of China
  funderid: 81503135
– fundername: Beijing Municipal Administration of Hospitals’ Youth Programme
  funderid: QML20160703
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1L6
1OC
29K
31~
33P
3SF
3V.
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
88A
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ABQWH
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFKRA
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BBNVY
BDRZF
BENPR
BFHJK
BHBCM
BHPHI
BMXJE
BPHCQ
BROTX
BRXPI
BVXVI
BY8
C45
CCPQU
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GNP
GODZA
H.X
HBH
HCIFZ
HF~
HGLYW
HHY
HHZ
HMCUK
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LK8
LOXES
LP6
LP7
LUTES
LW6
LYRES
M0L
M1P
M7P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
PROAC
PSQYO
Q.N
Q11
Q2X
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
SV3
TEORI
UB1
UKHRP
V2E
W8V
W99
WBKPD
WIH
WIJ
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXI
WXSBR
WYISQ
X7M
XG1
XV2
ZZTAW
~IA
~WT
NPM
AAYXX
CITATION
7QP
7TK
7TM
8FD
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3490-293a0c752e14c265ef40749367ea350242ced4ae45a6325484970b2520d5a3733
IEDL.DBID DR2
ISSN 1099-498X
IngestDate Fri Aug 16 06:21:16 EDT 2024
Thu Oct 10 22:07:10 EDT 2024
Fri Aug 23 02:52:13 EDT 2024
Wed Oct 16 00:59:57 EDT 2024
Sat Aug 24 00:51:12 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords methotrexate
microRNA
methylenetetrahydrofolate reductase
acute lymphoblastic leukemia
genetic polymorphism
Language English
License Copyright © 2017 John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3490-293a0c752e14c265ef40749367ea350242ced4ae45a6325484970b2520d5a3733
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9121-8168
PMID 28990296
PQID 1968957406
PQPubID 42608
PageCount 7
ParticipantIDs proquest_miscellaneous_1949084961
proquest_journals_1968957406
crossref_primary_10_1002_jgm_2990
pubmed_primary_28990296
wiley_primary_10_1002_jgm_2990_JGM2990
PublicationCentury 2000
PublicationDate November 2017
2017-Nov
2017-11-00
20171101
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: November 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle The journal of gene medicine
PublicationTitleAlternate J Gene Med
PublicationYear 2017
Publisher Wiley Periodicals Inc
Publisher_xml – name: Wiley Periodicals Inc
References 2007; 104
2010; 10
2009; 46
2002; 30
2013; 24
2010; 101
2015; 11
1995; 10
2011; 57
2013; 121
2012; 16
2007; 52
2007; 31
2012; 33
2006; 354
2006; 80
2006; 85
2011; 108
2017; 15
2013; 98
2009; 50
2006; 28
2015; 2015
2014; 37
2009; 146
2008; 68
2008; 22
2014; 74
2010; 70
1983; 309
2008; 371
1977; 297
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_11_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
Eissa DS (e_1_2_6_17_1) 2013; 24
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 33
  start-page: 581
  year: 2012
  end-page: 586
  article-title: The role of microRNA‐binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes
  publication-title: Carcinogenesis
– volume: 10
  start-page: 111
  year: 1995
  end-page: 113
  article-title: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  publication-title: Nat Genet
– volume: 16
  start-page: 8
  year: 2012
  end-page: 21
  article-title: Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer
  publication-title: J Cell Mol Med
– volume: 121
  start-page: 5145
  year: 2013
  end-page: 5153
  article-title: Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia
  publication-title: Blood
– volume: 28
  start-page: 64
  year: 2006
  end-page: 68
  article-title: Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high‐dose methotrexate‐induced toxicities in children with acute lymphoblastic leukemia or lymphoma
  publication-title: J Pediatr Hematol Oncol
– volume: 146
  start-page: 489
  year: 2009
  end-page: 503
  article-title: Advances in individual prediction of methotrexate toxicity: a review
  publication-title: Br J Haematol
– volume: 80
  start-page: 468
  year: 2006
  end-page: 476
  article-title: High‐dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations
  publication-title: Clin Pharmacol Ther
– volume: 108
  start-page: 13653
  year: 2011
  end-page: 13658
  article-title: Functional SNP in the microRNA‐367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification
  publication-title: Proc Natl Acad Sci USA
– volume: 371
  start-page: 1030
  year: 2008
  end-page: 1043
  article-title: Acute lymphoblastic leukemia
  publication-title: Lancet
– volume: 68
  start-page: 8535
  year: 2008
  end-page: 8540
  article-title: A SNP in a let‐7 microRNA complementary site in the KRAS 3′ untranslated region increases non‐small cell lung cancer risk
  publication-title: Cancer Res
– volume: 85
  start-page: 291
  year: 2006
  end-page: 300
  article-title: MTHFR 677 (C → T) polymorphism is not relevant for prognosis or therapy‐associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL‐BFM 95
  publication-title: Ann Hematol
– volume: 297
  start-page: 630
  year: 1977
  end-page: 634
  article-title: Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity
  publication-title: N Engl J Med
– volume: 46
  start-page: 52
  year: 2009
  end-page: 63
  article-title: Treatment of childhood acute lymphoblastic leukemia
  publication-title: Semin Hematol
– volume: 309
  start-page: 1094
  year: 1983
  end-page: 1104
  article-title: The pharmacology and clinical use of methotrexate
  publication-title: N Engl J Med
– volume: 37
  start-page: 576
  year: 2014
  end-page: 582
  article-title: Methylenetetrahydrofolate reductase polymorphisms and susceptibility to acute lymphoblastic leukemia in a Chinese population: a meta‐analysis
  publication-title: Oncol Res Treat
– volume: 70
  start-page: 2789
  year: 2010
  end-page: 2798
  article-title: Single‐nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility
  publication-title: Cancer Res
– volume: 98
  start-page: 702
  year: 2013
  end-page: 707
  article-title: Influence of pre‐hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high‐dose methotrexate therapy
  publication-title: Int J Hematol
– volume: 10
  start-page: 389
  year: 2010
  end-page: 402
  article-title: Genetic variation in microRNA networks: the implications for cancer research
  publication-title: Nat Rev Cancer
– volume: 354
  start-page: 166
  year: 2006
  end-page: 178
  article-title: Treatment of acute lymphoblastic leukemia
  publication-title: N Engl J Med
– volume: 101
  start-page: 782
  year: 2010
  end-page: 786
  article-title: Methylenetetrahydrofolate reductase polymorphisms, serum methylenetetrahydrofolate reductase levels, and risk of childhood acute lymphoblastic leukemia in a Chinese population
  publication-title: Cancer Sci
– volume: 31
  start-page: 1669
  year: 2007
  end-page: 1674
  article-title: MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients
  publication-title: Leuk Res
– volume: 57
  start-page: 612
  year: 2011
  end-page: 619
  article-title: Polymorphisms of the SLCO1B1 gene predict methotrexate‐related toxicity in childhood acute lymphoblastic leukemia
  publication-title: Pediatr Blood Cancer
– volume: 15
  start-page: 82
  year: 2017
  end-page: 93
  article-title: The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment
  publication-title: Genomics Proteomics Bioinformatics
– volume: 104
  start-page: 13513
  year: 2007
  end-page: 13518
  article-title: miR‐24 microRNA binding‐site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance
  publication-title: Proc Natl Acad Sci USA
– volume: 30
  start-page: 363
  year: 2002
  end-page: 364
  article-title: are complementary to 3′ UTR sequence motifs that mediate negative post‐transcriptional regulation
  publication-title: Nat Genet
– volume: 74
  start-page: 283
  year: 2014
  end-page: 289
  article-title: Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia
  publication-title: Cancer Chemother Pharmacol
– volume: 11
  start-page: 677
  year: 2015
  end-page: 681
  article-title: Let‐7b binding site polymorphism in the B‐cell lymphoma‐extra large 3′ UTR is associated with fluorouracil resistance of hepatocellular carcinoma
  publication-title: Mol Med Rep
– volume: 2015
  start-page: 751703
  year: 2015
  article-title: Methotrexate associated renal impairment is related to delayed elimination of high‐dose methotrexate
  publication-title: Sci World J
– volume: 22
  start-page: 1798
  year: 2008
  end-page: 1800
  article-title: Polymorphisms in folate‐related genes: association with side effects of high‐dose methotrexate in childhood acute lymphoblastic leukemia
  publication-title: Leukemia
– volume: 52
  start-page: 166
  year: 2007
  end-page: 171
  article-title: Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma
  publication-title: J Hum Genet
– volume: 50
  start-page: 912
  year: 2009
  end-page: 917
  article-title: Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy‐related toxicity in children treated for acute lymphoblastic leukemia and non‐Hodgkin lymphoma
  publication-title: Leuk Lymphoma
– volume: 24
  start-page: 181
  year: 2013
  end-page: 188
  article-title: C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate‐related toxicity in adult acute lymphoblastic leukaemia
  publication-title: Blood Coagul Fibrinolysis
– ident: e_1_2_6_24_1
  doi: 10.1016/j.leukres.2007.03.028
– ident: e_1_2_6_7_1
  doi: 10.1007/s10038-006-0096-z
– ident: e_1_2_6_2_1
  doi: 10.1056/NEJM198311033091805
– ident: e_1_2_6_3_1
  doi: 10.1056/NEJMra052603
– ident: e_1_2_6_32_1
  doi: 10.1158/0008-5472.CAN-08-2129
– ident: e_1_2_6_5_1
  doi: 10.1016/S0140-6736(08)60457-2
– ident: e_1_2_6_20_1
  doi: 10.1093/carcin/bgr300
– ident: e_1_2_6_25_1
  doi: 10.1007/s12185-013-1464-z
– ident: e_1_2_6_29_1
  doi: 10.1111/j.1582-4934.2011.01359.x
– ident: e_1_2_6_19_1
  doi: 10.1038/ng865
– ident: e_1_2_6_31_1
  doi: 10.1158/0008-5472.CAN-09-3541
– ident: e_1_2_6_13_1
  doi: 10.1038/leu.2008.66
– ident: e_1_2_6_33_1
  doi: 10.3892/mmr.2014.2692
– ident: e_1_2_6_23_1
  doi: 10.1038/ng0595-111
– ident: e_1_2_6_11_1
  doi: 10.1002/pbc.23074
– ident: e_1_2_6_30_1
  doi: 10.1073/pnas.1103360108
– ident: e_1_2_6_27_1
  doi: 10.1097/01.mph.0000198269.61948.90
– ident: e_1_2_6_4_1
  doi: 10.1053/j.seminhematol.2008.09.007
– ident: e_1_2_6_28_1
  doi: 10.1007/s00277-005-0072-2
– ident: e_1_2_6_8_1
  doi: 10.1016/j.clpt.2006.08.012
– ident: e_1_2_6_15_1
  doi: 10.1159/000368104
– ident: e_1_2_6_9_1
  doi: 10.1056/NEJM197709222971203
– volume: 24
  start-page: 181
  year: 2013
  ident: e_1_2_6_17_1
  article-title: C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate‐related toxicity in adult acute lymphoblastic leukaemia
  publication-title: Blood Coagul Fibrinolysis
  doi: 10.1097/MBC.0b013e32835b249d
  contributor:
    fullname: Eissa DS
– ident: e_1_2_6_26_1
  doi: 10.1007/s00280-014-2507-8
– ident: e_1_2_6_6_1
  doi: 10.1111/j.1365-2141.2009.07765.x
– ident: e_1_2_6_12_1
  doi: 10.1016/j.gpb.2016.11.003
– ident: e_1_2_6_22_1
  doi: 10.1111/j.1349-7006.2009.01429.x
– ident: e_1_2_6_14_1
  doi: 10.1080/10428190902893819
– ident: e_1_2_6_18_1
  doi: 10.1038/nrc2867
– ident: e_1_2_6_21_1
  doi: 10.1073/pnas.0706217104
– ident: e_1_2_6_10_1
  doi: 10.1155/2015/751703
– ident: e_1_2_6_16_1
  doi: 10.1182/blood-2013-01-480335
SSID ssj0017889
Score 2.291482
Snippet Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia...
The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL). The aim...
Abstract Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic...
Background The pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia...
BACKGROUNDThe pharmacokinetics and therapeutic response to methotrexate (MTX) display large variability in the treatment of acute lymphoblastic leukemia (ALL)....
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 353
SubjectTerms 3' Untranslated regions
Acute lymphoblastic leukemia
Binding sites
Children
Computer applications
Fluorescence
Fluorescence polarization
Gene frequency
Gene regulation
Gene therapy
genetic polymorphism
Genomes
Genotyping
Haplotypes
Immunoassay
Leukemia
Linkage disequilibrium
Lymphatic leukemia
Methotrexate
Methylenetetrahydrofolate reductase
microRNA
MicroRNAs
miRNA
Pediatrics
Pharmacokinetics
Population genetics
Population studies
Post-transcription
Title Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjgm.2990
https://www.ncbi.nlm.nih.gov/pubmed/28990296
https://www.proquest.com/docview/1968957406
https://search.proquest.com/docview/1949084961
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhUMilr_SxbRqmEHrzRrYk2zqG0s0S2ByWBBZ6MJKsbbeJ7SVeQ9P_0v_aGT82SUuh9OSDPZKs0eMbjeYbxo6EdstQ2TTIUyMC2vECK5YuMDxP_JITozkFOM_O4-mlPFuoRX-rkmJhOn6I7YEbzYx2vaYJbmx9fEca-u1LMaa1FJdf4tEjPDTfMkeFaNnp1tGpKYlauhh4Z3l0PAg-3In-gJcP0Wq73UyesM9DQ7tbJlfjZmPH7sdvHI7_9ydP2eMehcJJN2yesR1fPmePuryUt_vs5z2lQX-TC2YX08kcCrrANz8_Abtq42GAvM-wrq5viwpVtqqLGkyZQ5uZenPjvyOWBUexkWVP0FvDqgRK2-1rFBwyhUBP8FoDnQyDcQ3KYaHrr5VFgI_thGvfXPliZV6wy8mni4_ToM_jEDghNQ8QURjuEhX5ULooVn6JVqTUIk68EYpAgvO5NF4qEws0WFOpE24jFfFcGZEI8ZLtllXpXzMg7hlLzkoe5tKi9Z4Q4nUyznFYeW9H7P2g02zd0XVkHTFzlGE3Z9TNI3YwKDvrJ2yd4UKUapUgvMEitq9xqpH_xJS-augb8pJKHYcj9qobJNtKyG7lkUbpD62q_1p7dnY6o-ebf_3wLduLCEq08Y8HbHdz0_h3CIQ29rAd8r8A91kGUg
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tixBceC8UFjAS4pZuEttJLE4roJRl20PVlXpAimzHhbKbpNo0Est_4b8yk0dhQUiIUw6JH_F47G88nm8AXnBll4E0iZclmnu043mGL62n_Sx2S58YzSnAeTKNxifiaCEXO_Cqj4Vp-SG2B26kGc16TQpOB9IHP1lDv3zKh7SYXoGrqO2StPLNbMsdFaBtpxpXp6I0asmiZ571w4O-5OW96A-AeRmvNhvO6BZ87Lva3jM5HdYbM7TffmNx_M9_uQ03OyDKDtuZcwd2XHEXrrWpKS_uwfdf5Ma6y1xsMh-PZiynO3yz6SEzqyYkhpEDmq3Ls4u8RKmtqrxiushYk5x6c-6-IpxllsIji46jt2KrglHmbldhwT5ZCOs4XitGh8NM2xrLYaXrz6VBjI_9ZGeuPnX5St-Hk9Hb-eux16Vy8CwXyvcQVGjfxjJ0gbBhJN0SDUmheBQ7zSXhBOsyoZ2QOuJosyZCxb4JZehnUvOY8z3YLcrCPQRG9DOG_JV-kAmDBnxMoNeKKMOZ5ZwZwPNeqOm6ZexIW27mMMVhTmmYB7DfSzvtdLZKcS1KlIwR4WAV29eobeRC0YUra_qGHKVCRcEAHrSzZNsIma5-qLD0y0bWf209PXo3oeejf_3wGVwfzyfH6fH76YfHcCMkZNGEQ-7D7ua8dk8QF23M02b-_wBWbApy
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSF92NpASMhbtk6fiTrY0W7LIVdoVUrrcQhsh0HljbJqtlIlP_Cf-1MHlsKQkKcckjGdjx-fOPxfEPIa6FdFio7CtKREQHueIEVmQsMS2OfMWQ0xwDn6SyaHMvDhVp0tyoxFqblh9gcuOHMaNZrnOCrNNu9JA399iUf4lp6ndyQkeBoeO3PN9RRIZh2uvF0asyiNlr0xLOM7_aSV7eiP_DlVbja7Dfju-Rz39L2msnJsF7bofvxG4nj__3KPXKng6F0rx0398k1XzwgN9vElOcPyc9ftEa7q1x0ejQZz2mON_jmsz1ql01ADEX3M12Vp-d5CTpbVnlFTZHSJjX1-sx_BzBLHQZHFh1Db0WXBcW83b4CwT5VCO0YXiuKR8PUuBrkoNDV19ICwod20lNfn_h8aR6R4_HB0dtJ0CVyCJyQmgUAKQxzseI-lI5HymdgRkototgboRAlOJ9K46UyoEmwoaSOmeWKs1QZEQvxmGwVZeGfEorkMxa9lSxMpQXzPUbI62SUwrjy3g7Iq16nyarl60haZmaeQDcn2M0DstMrO-lmbJXASjTSKgZ8A0VsXsNcQweKKXxZ4zfoJpU6CgfkSTtINpWg4cq4Buk3jar_Wnty-G6Kz2f_-uFLcuvT_jj5-H72YZvc5ggrmljIHbK1Pqv9cwBFa_uiGf0XOaYJIQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+MTHFR+microRNA+binding+site+polymorphisms+and+methotrexate+concentrations+in+Chinese+pediatric+patients+with+acute+lymphoblastic+leukemia&rft.jtitle=The+journal+of+gene+medicine&rft.au=Wang%2C+Shu-Mei&rft.au=Zeng%2C+Wei-Xin&rft.au=Wu%2C+Wan-Shui&rft.au=Sun%2C+Lu-Lu&rft.date=2017-11-01&rft.eissn=1521-2254&rft.volume=19&rft.issue=11&rft.spage=353&rft.epage=359&rft_id=info:doi/10.1002%2Fjgm.2990&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-498X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-498X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-498X&client=summon